LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUERIN THERAPY

被引：0
|
作者：
Robins, Dennis J.
Sui, Wilson
Matulay, Justin T.
DeCastro, G. Joel
Anderson, Christopher B.
McKiernan, James M.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.3263
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP21-01
引用
收藏
页码：E247 / E248
页数：2
相关论文
共 50 条
  • [21] Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer
    Alon Z. Weizer
    Christopher Tallman
    Jeffrey S. Montgomery
    [J]. World Journal of Urology, 2011, 29 : 59 - 71
  • [22] Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin
    Muller, D. C.
    Bacon, J. V. W.
    Ritch, E.
    Dugas, S. G.
    Vandekerkhove, G.
    Annala, M.
    Black, P. C.
    Seifert, H.
    Bubendorf, L.
    Wyatt, A. W.
    Rentsch, C. A.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S617 - S617
  • [23] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [24] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [25] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
  • [26] UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER
    Lenis, Andrew
    Litwin, Mark
    Saigal, Christopher
    Donin, Nicholas
    Lai, Julie
    Hanley, Jan
    Konety, Badrinath
    Chamie, Karim
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [27] Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer.
    Alanee, Shaheen
    Hamilton, Robert James
    Joseph, Vijai
    Ostrovnaya, Irina
    Garcia-Grossman, Ilana Rebecca
    Gallagher, David J.
    Pendse, Deepa
    Regazzi, Ashley Marie
    Przybylo, Jennifer A.
    Gaudet, Mia
    Milowsky, Matthew I.
    Herr, Harry W.
    Offit, Kenneth
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] INTRAVESICAL GEMCITABINE VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: AN EVALUATION OF EFFICACY AND TOLERANCE
    Prasanna, T.
    Kuo, J. C.
    Hickie, M.
    Sim, B. W. C.
    Pranavan, G.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 35 - 35
  • [29] LONG-TERM RESULTS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER
    SAROSDY, MF
    LAMM, DL
    [J]. JOURNAL OF UROLOGY, 1989, 142 (03): : 719 - 722
  • [30] Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
    Prasanna, Thiru
    Craft, Paul
    Balasingam, Gayathri
    Haxhimolla, Hodo
    Pranavan, Ganes
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
12345